Download or read book Federal 340B Drug Pricing Program written by Erica Kramer and published by . This book was released on 2022 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The federal 340B Drug Pricing Program provides access to reduced-price drugs for eligible health care providers registered with the U.S. Department of Health and Human Services as “covered entities.” These covered entities include facilities that serve vulnerable communities.Under the program, 340B covered entities may purchase select outpatient and over-the-counter drugs at discounted prices. These prices are at least as low as the price state Medicaid agencies pay for the same drugs and are often lower. To receive 340B discounted drugs, an individual must be a patient of a 340B entity. In recent years, the number of 340B covered entities has increased dramatically.
Download or read book The 340B Drug Pricing Program written by Felix C. Larsen and published by Nova Snova. This book was released on 2020-05-12 with total page 340 pages. Available in PDF, EPUB and Kindle. Book excerpt: The 340B Drug Pricing Program (340B Program) and the Medicaid Drug Rebate Program require manufacturers to provide discounts on outpatient drugs in order to have their drugs covered by Medicaid. These discounts take the form of reduced sales prices for covered entities participating in the 340B Program--eligible hospitals and federal grantees--and rebates on drugs dispensed to Medicaid beneficiaries, shared by states and the federal government. This book looks at important issues pertaining to the 340B Drug Pricing Program.
Download or read book Drug Pricing written by Debra A. Draper and published by . This book was released on 2011-09-23 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: The Health Resources and Services Admin. (HRSA) oversees the 340B Drug Pricing Program, through which participating drug manufacturers give certain entities within the health care safety net -- known as covered entities (CE) -- access to discounted prices on outpatient drugs. CE include specified fed. grantees and hospitals. The number of CE sites has nearly doubled in the past 10 years to over 16,500. This study examines: (1) the extent to which CE generate 340B revenue, factors that affect revenue generation, and how they use the program; (2) how manufacturers' dist. of drugs at 340B prices affects CE or non-340B providers' access to drugs; and (3) HRSA's oversight of the 340B program. Charts and tables. A print on demand report.
Download or read book Drug Pricing written by U.s. Government Accountability Office and published by . This book was released on 2017-08-14 with total page 54 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Health Resources and ServicesAdministration (HRSA), within in theDepartment of Health and HumanServices (HHS), oversees the 340BDrug Pricing Program, through whichparticipating drug manufacturers givecertain entities within the health caresafety net-known as coveredentities-access to discounted priceson outpatient drugs. Covered entitiesinclude specified federal grantees andhospitals. The number of coveredentity sites has nearly doubled in thepast 10 years to over 16,500.The Patient Protection and AffordableCare Act (PPACA) mandated that GAOaddress questions related to the 340Bprogram. GAO examined: (1) theextent to which covered entitiesgenerate 340B revenue, factors thataffect revenue generation, and howthey use the program; (2) howmanufacturers' distribution of drugs at340B prices affects covered entities' ornon-340B providers' access to drugs;and (3) HRSA's oversight of the 340Bprogram. GAO reviewed key laws andguidance, analyzed relevant data, andconducted interviews with 61 340Bprogram stakeholders selected torepresent a range of perspectives,including HRSA, 29 covered entities,10 manufacturers and representatives,and 21 others. Selection ofstakeholders was judgmental and thus,responses are not generalizable. "
Download or read book Prescription Drug Pricing Background Discount Programs and Cost Lowering Strategies written by Elias B. Toft and published by Nova Snova. This book was released on 2020-03-13 with total page 248 pages. Available in PDF, EPUB and Kindle. Book excerpt: Chapter 1 examines the actions of drug companies in raising prescription drug prices in the United States, as well as the effects of these actions on the Federal and state budgets, and on American families. Chapter 2 addresses frequently asked questions about government and private-sector policies that affect drug prices and availability. Among the prescription drug topics covered are federally funded research and development, regulation of direct-to-consumer advertising, legal restrictions on reimportation, and federal price negotiation. The 340B Drug Pricing Program requires drug manufacturers to sell outpatient drugs at discounted prices to covered entitiesâeligible clinics, hospitals, and othersâin order to have their drugs covered by Medicaid. Covered entities are only allowed to provide 340B drugs to certain eligible patients. Chapter 3 reviews the Health Resources and Services Administration's (HRSA) oversight of the 340B Program to ensure compliance with program rules. In 2017, nearly 60% of U.S. adults aged 18â64 reported being prescribed medication in the past 12 months. Approximately 70% of prescription medications carry out-of-pocket costs. Strategies to reduce prescription drug costs at the individual level are discussed in chapters 4 and 5. Each year, Americans pay more for prescription drugs, and rising drug prices have a disproportionate impact on older Americans. Chapter 6 examines the history of rising drug prices for the brand-name drugs most commonly prescribed for seniors. Generic drugsâcopies of brand-name drugsâlead to significant cost savings. Before a generic drug can be marketed, FDA must approve the generic drug application. According to FDA, applications go through an average of three cycles of review before being approved, which may take years. Chapter 7 examines 1) the first review cycle approval rate of generic drug applications in recent years and factors that may have contributed to whether applications were approved; and 2) changes FDA has made to increase the first review cycle approval rate.
Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Download or read book Prescription Drugs Oversight of Drug Pricing in Federal Programs written by and published by DIANE Publishing. This book was released on 2007 with total page 18 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Drug pricing written by United States. Government Accountability Office and published by . This book was released on 2011 with total page 49 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Oversight and Administration of the 340B Drug Discount Program written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations and published by . This book was released on 2006 with total page 80 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Final Report Establishing a Commission to Study Pharmaceutical Costs and the 340B Drug Pricing Program written by New Hampshire. General Court and published by . This book was released on 2008 with total page 12 pages. Available in PDF, EPUB and Kindle. Book excerpt: The creation of the commission was to study obtaining greater efficiencies and cost savings in public pharmaceutical costs through increased participation in the federal 340B Drug Pricing Program with particular emphasis on Medicaid and inmate populations.
Download or read book Prescription Drugs An Overview of Approaches to Negotiate Drug Prices Used by Other Countries U S Private Payers Federal Programs written by and published by DIANE Publishing. This book was released on with total page 22 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Interim Report Establishing a Commission to Study Pharmaceutical Costs and the 340B Drug Pricing Program written by New Hampshire. General Court and published by . This book was released on 2007 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt: The creation of the commission was to study obtaining greater efficiencies and cost savings in public pharmaceutical costs through increased participation in the federal 340B Drug Pricing Program with particular emphasis on Medicaid and inmate populations.
Download or read book Final Report on HB 148 Chapter 245 1 Laws of 2007 written by New Hampshire. General Court. Commission to Study Pharmaceutical Costs and the 340B Drug Pricing Program and published by . This book was released on 2008 with total page 12 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The creation of the commission was to study obtaining greater efficiencies and cost savings in public pharmaceutical costs through increased participation in the federal 340B Drug Pricing Program with particular emphasis on Medicaid and inmate populations." --[Leaf 2].
Download or read book Prescription Drugs written by Laura A. Dummit and published by DIANE Publishing. This book was released on 2008-06 with total page 26 pages. Available in PDF, EPUB and Kindle. Book excerpt: In 2000, as the Congress considered adding a prescription drug (PD) benefit to Medicare, there was increased interest in understanding the ways that gov¿t. purchasers have controlled their costs for PD and whether these methods can be used to reduce PD costs for Medicare beneficiaries. One proposal would allow Medicare beneficiaries to purchase PD from pharmacies at the same prices that are available to fed. purchasers or state Medicaid programs. This report provides information on: the fed. drug price discounts available to fed. and non-fed. purchasers and the size of those discounts; and the potential effects that extending such discounts to non-fed. purchasers may have on outpatient drug prices paid by fed. and non-fed. purchasers. Illus.
Download or read book Examining the 340B Drug Pricing Program written by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and published by . This book was released on 2015 with total page 112 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Confessionalidade e constru o tica na universidade written by ANA MARIA CASTANHEIRA and published by . This book was released on 2008 with total page 295 pages. Available in PDF, EPUB and Kindle. Book excerpt: A avaliação institucional já é uma realidade indiscutível para as instituições de ensino superior que precisam estar aptas para implantar ações avaliativas, que envolvam diversos segmentos, e que resultem na verdadeira melhoria da qualidade da educação brasileira. O objetivo desta obra é a proposição de processos avaliativos simples, que, se bem conduzidos, levam à real discussão dos resultados e podem transformar-se em indicadores da maior relevância para a tomada de decisão, colaborando significativamente com o desenvolvimento da instituição, além de atender às orientações do Sistema Nacional de Avaliação da Educação Superior (Sinaes).
Download or read book Drug Discount Program Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement written by United States. Government Accountability Office and published by . This book was released on 2018 with total page 62 pages. Available in PDF, EPUB and Kindle. Book excerpt:
